We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M Turnover 17.65%
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
-21.03%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
–
Cap. Flow
+$1.35B
Cap. Flow %
118.56%
Top 10 Hldgs %
95.42%
Holding
25
New
25
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$383M
2
FATE icon
Fate Therapeutics
FATE
+$265M
3
ARWR icon
Arrowhead Research
ARWR
+$211M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$104M
5
HLTH icon
Cue Health Inc. Common Stock
HLTH
+$87.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.89%
2 Technology 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ILMN icon
1
Illumina
ILMN
$41B
$329M 28.83%
+832,855
New +$383M
2021 Q3
0 quarters
ARWR icon
2
Arrowhead Research
ARWR
$8.25B
$204M 17.86%
+3,260,869
New +$211M
2021 Q3
0 quarters
FATE icon
3
Fate Therapeutics
FATE
$232M
$200M 17.57%
+3,379,064
New +$265M
2021 Q3
0 quarters
LEGN icon
4
Legend Biotech
LEGN
$3.7B
$82.4M 7.23%
+1,629,173
New +$67.8M
2021 Q3
0 quarters
HLTH icon
5
DELISTED
Cue Health Inc. Common Stock
HLTH
$65.5M 5.75%
+5,548,864
New +$87.4M
2021 Q3
0 quarters
CVRX icon
6
CVRx
CVRX
$35.7M
$57.8M 5.07%
+3,495,575
New +$67.1M
2021 Q3
0 quarters
PTGX icon
7
Protagonist Therapeutics
PTGX
$8.82B
$43.4M 3.81%
+2,449,183
New +$104M
2021 Q3
0 quarters
PRCT icon
8
Procept Biorobotics
PRCT
$1B
$38.9M 3.41%
+1,018,478
New +$39.1M
2021 Q3
0 quarters
MGTX icon
9
MeiraGTx Holdings
MGTX
$904M
$38.2M 3.35%
+2,898,550
New +$39.7M
2021 Q3
0 quarters
FUSN icon
10
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$29.1M 2.55%
+3,670,516
New +$30.9M
2021 Q3
0 quarters
VOR icon
11
Vor Biopharma
VOR
$1.11B
$16.9M 1.48%
+53,733
New +$16M
2021 Q3
0 quarters
PNT
12
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$7.69M 0.67%
+1,000,000
New +$9.12M
2021 Q3
0 quarters
HLSQ
13
Tessera Defense and Homeland Security Inc.
HLSQ
$2.15M
$6.53M 0.57%
+1,123
New +$8.7M
2021 Q3
0 quarters
ACET icon
14
Adicet Bio
ACET
$45.8M
$5.71M 0.5%
+45,559
New +$5.65M
2021 Q3
0 quarters
PHAS
15
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$5M 0.44%
+1,607,044
New +$5.36M
2021 Q3
0 quarters
SLGC
16
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$3.48M 0.31%
+281,052
New +$3.17M
2021 Q3
0 quarters
ALDX icon
17
Aldeyra Therapeutics
ALDX
$47.7M
$3.47M 0.3%
+394,834
New +$3.62M
2021 Q3
0 quarters
CSLT
18
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.27M 0.11%
+811,295
New +$1.59M
2021 Q3
0 quarters
NPCE icon
19
Neuropace
NPCE
$431M
$879K 0.08%
+55,435
New +$1.16M
2021 Q3
0 quarters
TCON
20
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$325K 0.03%
+4,200
New +$356K
2021 Q3
0 quarters
GYRE icon
21
Gyre Therapeutics
GYRE
$686M
$275K 0.02%
+8,927
New +$294K
2021 Q3
0 quarters
ZY
22
DELISTED
Zymergen Inc. Common Stock
ZY
$218K 0.02%
+16,553
New +$351K
2021 Q3
0 quarters
LUNG icon
23
Pulmonx
LUNG
$76.4M
$203K 0.02%
+5,639
New +$222K
2021 Q3
0 quarters
SENS icon
24
Senseonics Holdings Inc
SENS
$428M
$185K 0.02%
+2,731
New +$185K
2021 Q3
0 quarters
CALC icon
25
CalciMedica
CALC
$7.31M
$164K 0.01%
+708
New +$199K
2021 Q3
0 quarters

Similar funds

SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
TI
TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $798M AUM 18.61% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $798M AUM 8.86% 1-Year Est. Return
LOPW
Live Oak Private Wealth Wilmington, North Carolina $800M AUM 24.59% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $800M AUM 23.65% 1-Year Est. Return
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 22.73% 1-Year Est. Return

Johnson & Johnson's Q3 2021 Portfolio in Review

Q3 2021 is the first quarter with a 13F filing on record for Johnson & Johnson, which disclosed 25 positions worth $1.14B. Its ten largest holdings account for 95% of the portfolio.

Its largest position is Illumina: 832,855 shares worth $329M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Technology.

  • Johnson & Johnson's largest Q3 2021 buy was Illumina: 832,855 shares worth $329M.
  • Johnson & Johnson's ten largest holdings make up 95% of its $1.14B portfolio in Q3 2021.
  • Johnson & Johnson disclosed 25 positions in Q3 2021, its first 13F filing on record.

Based on Johnson & Johnson's 13F filing for Q3 2021, filed 12 Nov 2021.